Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Leap Therapeutics, Inc. (LPTX) had Return on Investments of -192.75% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-67.79M |
|
-- |
|
-- |
|
$70.06M |
|
$-70.06M |
|
$3.09M |
|
$-66.97M |
|
$-66.97M |
|
$-67.56M |
|
$-67.56M |
|
$-67.56M |
|
$-67.56M |
|
$-70.06M |
|
$-70.05M |
|
37.55M |
|
37.55M |
|
$-1.81 |
|
$-1.81 |
|
| Balance Sheet Financials | |
$48.04M |
|
-- |
|
$1.08M |
|
$49.12M |
|
$14.08M |
|
-- |
|
-- |
|
$14.08M |
|
$35.05M |
|
$35.05M |
|
$35.05M |
|
38.33M |
|
| Cash Flow Statement Financials | |
$-60.30M |
|
-- |
|
$37.18M |
|
$70.64M |
|
$47.25M |
|
$-23.39M |
|
$5.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-60.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-192.75% |
|
-192.75% |
|
-137.52% |
|
|
Return on Investments |
-192.75% |
$0.91 |
|
$-1.61 |
|
$-1.61 |
|